CATX
Perspective Therapeutics Inc.
2.50$
-4.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2010 | 2011 | 2011 | 2012 | 2012 | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.3% | 86.3% | 77.9% | 77.9% | 86.1% | 86.1% | 96.7% | 96.7% | 104.7% | 104.7% | 96.4% | 96.4% | 97.3% | 97.3% | 82.4% | 82.4% | 68.9% | 58.3% | 58.3% | 47.1% | 47.1% | 49.1% | 49.1% | 57.2% | 57.2% | 56.3% | 77.0% | – | 158.6% | 367.8% | |
| 13.7% | 13.7% | 22.1% | 22.1% | 13.9% | 13.9% | 3.3% | 3.3% | -4.7% | -4.7% | 3.6% | 3.6% | 2.7% | 2.7% | 17.6% | 17.6% | 31.1% | 41.7% | 41.7% | 52.9% | 52.9% | 50.9% | 50.9% | 42.8% | 42.8% | 43.7% | 23.0% | 100.0% | -58.6% | -267.8% | |
| 6.5% | 6.5% | 8.9% | 8.9% | 14.4% | 14.4% | 13.9% | 13.9% | 15.9% | 15.9% | 13.3% | 13.3% | 11.1% | 11.1% | 20.3% | 20.3% | 29.5% | 20.2% | 20.2% | 11.6% | 11.6% | 14.2% | 14.2% | 23.9% | 23.9% | 33.5% | 36.6% | 1,486.1% | 2,705.1% | 9,526.6% | |
| 46.2% | 46.2% | 46.2% | 46.2% | 46.4% | 46.4% | 50.7% | 50.7% | 59.0% | 59.0% | 52.1% | 52.1% | 79.4% | 79.4% | 82.3% | 82.3% | 70.3% | 57.0% | 57.0% | 47.2% | 47.2% | 46.7% | 46.7% | 87.3% | 61.3% | 172.7% | 153.0% | 1,462.1% | 1,830.3% | 3,420.0% | |
| 89.6% | 89.6% | 78.6% | 78.6% | 84.8% | 84.8% | 93.2% | 93.2% | 104.1% | 104.1% | 97.8% | 97.8% | 109.3% | 109.3% | 150.1% | 150.1% | 144.7% | 113.8% | 113.8% | 88.8% | 88.8% | 85.1% | 85.1% | 168.5% | 111.2% | 211.8% | 245.3% | 2,955.0% | 4,535.4% | 12,846.6% | |
| -75.8% | -75.8% | -56.6% | -56.6% | -71.0% | -71.0% | -89.9% | -89.9% | -108.7% | -108.7% | -94.1% | -94.1% | -106.6% | -106.6% | -132.5% | -132.5% | -113.6% | -72.2% | -72.2% | -35.9% | -35.9% | -34.2% | -34.2% | -68.5% | -68.5% | -168.1% | -213.7% | -2,855.0% | -4,594.0% | -12,846.6% | |
| 0.7% | 0.7% | 4.1% | 4.1% | 1.2% | 1.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 3.0% | 3.0% | 0.5% | 0.4% | 1.8% | – | 0.3% | – | 0.5% | – | 1.1% | 2.2% | – | 5.9% | 3.3% | 42.5% | |
| – | – | -54.3% | -54.3% | -67.6% | -67.6% | -85.2% | -85.2% | -141.2% | -141.2% | -79.9% | -79.9% | -98.8% | -98.8% | -129.4% | -129.4% | -113.1% | -70.3% | -70.3% | -35.6% | -35.6% | -33.7% | -33.7% | -67.4% | -67.4% | -156.7% | -206.5% | -2,796.8% | -5,531.4% | -11,813.1% | |
| 0.5% | 0.5% | -2.3% | -2.3% | -2.2% | -2.2% | -4.7% | -4.7% | 32.5% | 32.5% | -14.2% | -14.2% | -7.8% | -7.8% | -3.0% | -3.0% | -0.5% | -4.0% | -4.0% | -1.8% | -1.8% | -2.0% | -2.0% | – | -1.1% | -2.2% | – | -184.9% | -144.2% | -89.7% | |
| -76.3% | -76.3% | -54.3% | -54.3% | -68.8% | -68.8% | -85.2% | -85.2% | -141.2% | -141.2% | -79.9% | -79.9% | -98.8% | -98.8% | -129.4% | -129.4% | -113.1% | -66.3% | -66.3% | -33.8% | -33.8% | -31.7% | -31.7% | -67.4% | -66.3% | -198.7% | -206.5% | -3,243.2% | -5,452.5% | -11,665.3% | |
| -57.0% | -57.0% | -39.5% | -39.5% | -57.6% | -57.6% | -73.5% | -73.5% | -92.2% | -92.2% | -88.0% | -88.0% | -92.1% | -92.1% | -130.0% | -130.0% | -113.1% | -70.3% | -72.5% | -35.9% | -34.4% | -34.1% | -34.1% | – | -66.2% | -156.6% | -208.9% | -2,786.6% | -4,435.4% | -11,402.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.